Lorena Alarcon-Casas Wright, M.D.
Metabolism, Endocrinology and Nutrition
Clinical Assistant Professor of Medicine
Dr. Wright received her medical degree from the University of Veracruz in Mexico. She completed one year of internship in Medicine in Mexico and worked at a rural clinic caring for an underserved population with chronic disorders including diabetes and obesity. She completed her internal medicine residency at Cottage Hospital in Santa Barbara, California, a community hospital affiliated to the University of Southern California. During her residency, Dr. Wright participated in research projects at the Sansum Diabetes Research Institute and at the Santa Barbara Diabetes-in-Pregnancy County Clinic.
Dr. Wright came to the University of Washington to fulfill her dream of becoming an endocrinologist and diabetologist. She completed a three-year research fellowship in Endocrinology, Nutrition and Metabolism and became a Clinical Assistant Professor in 2012.
Dr. Wright enjoys teaching endocrine fellows, residents and medical students through the UW fellowship program. In addition to clinical teaching and patient care responsibilities at the University of Washington Medical Center, Harborview Medical Center and The Diabetes Care Center, Dr. Wright participates in mentoring minority pre-med and medical students through the Underrepresented Medical Students (URM), the Center for Equity, Diversity, and Inclusion (CEDI) and the Office of Graduate Medical Education (GME) of the University of Washington.
Dr. Wright’s clinical work focuses on endocrinology care at the UWMC and Harborview clinics; and diabetes care at the Diabetes Care Center.
Dr. Wright’s research interests are in the areas of pre-diabetes, glycemic control and glycemic markers in diabetes and pregnancy complicated by diabetes. Dr. Wright is particularly interested in strategies to prevent and delay the progression of diabetes.
Faulenbach MV*, Wright LA*, Lorenzo C*, Utzschneider K, Goedecke J, Fujimoto W, Boyko E, McNeely M, Leonetti D, Haffner S, Kahn SE, and American Diabetes Association GENNID Study Group: Impact of Differences in Glucose Tolerance on the Prevalence of a Negative Insulinogenic Index. The Journal of Diabetes and its Complications 2013; 27: 158-161
Wright LA, Hirsch I. The Challenges of the Use of Glycemic Biomarkers in Diabetes Monitoring. Reflecting on Hemoglobin A1C, 1, 5-Anhydroglucitol, and the Glycated Proteins. Diabetes Spectrum 2012; 25: 141-148
Kahn SE, Suvag S, Wright LA, Utzschneider KM. Interactions Between Genetic Background, Insulin Resistance and Beta-cell Function. Diabetes, Obesity and Metabolism 2012; 14:46-56
Smits M, Boyko E, Utzschneider K, Leonetti D, McNeely M, Suvag S, Wright LA, Fujimoto W, Kahn SE: Arm Length is Associated with Type 2 Diabetes Mellitus in Japanese Americans. Diabetologia 2012; 55: 1679-1684
Marina A, Utzschneider K, Wright LA, Montgomery B, Marcovina S, Kahn SE: Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and Beta-Cell Function. Diabetes Care 2012; 35: 1119-1125
Trujillo A, Wright LA, Jovanovic L: Medical Management of Preexisting Diabetes in Pregnancy, in the book Diabetes in Women. Pathophysiology and Therapy 2010
Wright LA, Hirsch IB, Gooley TA, Bown Z, Jovanovic L. Third Trimester Hemoglobin A1C and its Association with Fetal Abdominal Circumference and Neonatal Birth Weight in Pregnancies Complicated by Pre-existing Diabetes. Poster Presentation at The 46th Annual Meeting of the Diabetes Pregnancy Study Group (DPSG), part of the European Association for the Study of Diabetes (EASD) 2014. Budapest, Hungary.
Perez E, Brown Z, Hirsch I, Wright LA, Pregnancy Complicated by Diabetes and Severe Insulin Resistance (SIR): Review of 8 Cases on U-500 Regular Insulin (U500); Diabetes 2014: 63, S1: A629
Wright LA, Vasudevan S, Huynh P, Smith R, Hirsch IB, Professional Continuous Glucose Monitoring Improves Hemoglobin A1C in Insulin-Requiring Diabetic Patients; Endocrine Reviews 2014, 35: MON-1004.
Kocarnik B, Wright LA. Recovery of Adrenal Axis after an Unusual Cause of Hypopituitarism. Endocrine Practice 2014; 927, p186
Noorhasan M, Wright LA. Atypical Presentation of Thyrotoxic Periodic Paralysis (TPP): Review of Four Cases. Endocrine Practice 2014; 1158, p237
Wright LA, Hirsch IB, Gooley TA, Brown Z: 1, 5-Anhydroglucitol and Neonatal Complications in Pregnancy Complicated by Diabetes. Diabetologia 2013; 56:S516
Wright LA, Hirsch IB, Gooley TA, Delaney SS, Brown Z: 1, 5-Anhydroglucitol is Strongly Associated with Neonatal Birth Weight across All trimesters in Pregnancy Complicated by Diabetes. Endocrine Reviews 2012; 30: SUN-LB4
Wright LA, Utzschneider KM, Tong J, Suvag S, Kahn SE: Short Term Mild Hyperglycemia Improves Oral Glucose Disposal and ß-Cell Function in Subjects with Impaired Glucose Tolerance (IGT). Diabetes 2012; Suppl (1): A444
Suvag S, Utzschneider KM, Wright L, Fish B, Kahn, SE: Decreased Insulin Responses to IV Glucose and Tolbutamide in Subjects with Impaired Fasting Glucose: Clues to Cellular Mechanisms for ß-Cell Failure? Diabetes 2012; Suppl (1): A451
Wright L, Lipkin E: Parathyroid Hyperfunction in a Patient with Paget’s disease of the Bone. The Endocrine Fellows Foundation/ American Society for Bone and Mineral Research Fifth Fellows Forum on Metabolic Bone Diseases 2011
Marina A, Utzschneider K, Wright L, Montgomery B, Marcovina S, Kahn SE: Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and Beta-Cell Function. Diabetes 2011; Suppl (1)
Wright LA, Adrenal Support-Fact versus Fiction. Empower Magazine 2012 Vol.4, Issue 4
Wright LA, Understanding Markers of Blood Sugar Control. Empower Magazine 2012 Vol. 4, Issue 2